CP-123 A cost effectiveness analysis of nivolumab compared with pemetrexed for the treatment of non-small cell lung cancer in real practice
2019 ◽
Vol Volume 11
◽
pp. 9195-9202
◽
2019 ◽
Vol 18
◽
pp. 1-7
◽
2019 ◽
Vol 40
(2)
◽
pp. 129-137
◽
2006 ◽
Vol 13
(2)
◽
pp. 109-126
◽
2019 ◽
Vol 22
(4)
◽
pp. 344-349
◽
2019 ◽
Vol 42
(11)
◽
pp. 837-844